Archive: 5 29 2024
The 'i4MDS' consortium looks to the future at its second general meeting
![i4MDS 1](/assets/Images/Events/i4MDS-1__ScaleMaxWidthWzY0MF0.jpg)
The International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—also known as ‘i4MDS’—held its second general meeting in The Hague from February 9–10, 2024.